C allele in transforming growth factor‐β1 rs1800471 gene polymorphisms might indicate a protective feature in encapsulating peritoneal sclerosis development-Reference-Cited by-同舟云学术

C allele in transforming growth factor‐β1 rs1800471 gene polymorphisms might indicate a protective feature in encapsulating peritoneal sclerosis development

Published:2022-08-24 Issue:2 Volume:27 Page:353-360
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Bora Feyza¹^ORCID,Aslan Bengisu¹,Sarı Funda¹,Yılmaz Fatih²^ORCID,Ersoy Fettah Fevzi¹,Köksoy Sadi³,Özdem Sebahat⁴,Küçükçetin İkbal Özen⁴,Sipahioğlu Murat⁵,Karakaya İbrahim⁶,Koç Yener⁷,Ulu Memnune Sena⁸

Affiliation:

1. Department of Internal Medicine, Division of Nephrology Akdeniz University Medical School Antalya Turkey

2. Department of Nephrology Antalya Atatürk State Hospital Antalya Turkey

3. Department of Medical Microbiology Akdeniz University Medical School Antalya Turkey

4. Department of Basic Medical Sciences, Medical Biochemistry Akdeniz University Medical School Antalya Turkey

5. Department of Internal Medicine, Division of Nephrology Erciyes University Medical School Kayseri Turkey

6. Department of Internal Medicine, Division of Nephrology Çukurova University Medical School Adana Turkey

7. Department of Internal Medicine, Division of Nephrology Cumhuriyet University Medical School Sivas Turkey

8. Department of Internal Medicine Division of Nephrology Bahçeşehir University Medical School Istanbul Turkey

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13913

Reference49 articles.

1. Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis Patients: Pathologic Significance and Potential Therapeutic Interventions

2. Morphological aspects of peritoneal sclerosis;Garosi G;J Nephrol,2001

3. Encapsulating Peritoneal Sclerosis

4. Pathology of Encapsulating Peritoneal Sclerosis

5. Patients with Encapsulating Peritoneal Sclerosis Have Increased Peritoneal Expression of Connective Tissue Growth Factor (CCN2), Transforming Growth Factor-β1, and Vascular Endothelial Growth Factor